Literature DB >> 28497759

Long-term challenges and perspectives of pre-adolescent liver disease.

Nedim Hadžić1, Ulrich Baumann2, Pat McKiernan3, Valerie McLin4, Valerio Nobili5.   

Abstract

Chronic liver disease is a growing problem that has substantial effects on public health. Many paediatric liver conditions are precursors of adult chronic liver disease, cirrhosis, and hepatocellular carcinoma. Clinical management of Wilson's disease, autoimmune liver disease, and chronic biliary disorders, such as biliary atresia, which remains the most common paediatric chronic liver disease and indication for liver transplantation, is similar in children and adults. In the past 10 or so years, paediatric hepatology has expanded into neighbouring clinical areas, such as metabolic liver diseases and systemic conditions with liver involvement. We aim to describe some of these disorders, and outline their natural history and possible differences between management in adults and children to stimulate further debate on the optimal transition of care between paediatric and adult specialists.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28497759     DOI: 10.1016/S2468-1253(16)30160-1

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  3 in total

Review 1.  [Biliary atresia and congenital cholestatic syndromes : Characteristics before, after and during transition].

Authors:  N Junge; J Dingemann; C Petersen; M P Manns; N Richter; J Klempnauer; U Baumann; A Schneider
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

Review 2.  Liver fibrosis: Pathophysiology and clinical implications.

Authors:  Jennifer Berumen; Jacopo Baglieri; Tatiana Kisseleva; Kristin Mekeel
Journal:  WIREs Mech Dis       Date:  2020-07-26

3.  Doppler ultrasound values after liver transplantation in children and their association with graft outcomes: a protocol for a systematic review and meta-analysis.

Authors:  Martha M Ruiz; Rashid Alobaidi; Michelle Lisa Noga; Robin Featherstone; James Shapiro; Ravi Bhargava
Journal:  BMJ Open       Date:  2019-12-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.